Myriad Genetics, Inc.:企業の戦略・SWOT・財務分析

【英語タイトル】Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(SWOT20MY4299)・商品コード:SWOT20MY4299
・発行会社(調査会社):MarketLine
・発行日:2020年2月
・ページ数:51
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥55,125見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Myriad Genetics, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Myriad Genetics, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Myriad Genetics, Inc. (Myriad or ‘the company’) is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. It operates a CLIA-certified laboratory facility in Salt Lake City, Utah to perform most of the molecular diagnostic tests; a CLIA-certified laboratory in South San Francisco, California; a single laboratory facility in Munich, Germany to perform the international molecular diagnostic tests; and a CLIA-certified laboratory facility in Austin, Texas. The company has operations in the US and Europe. The company is headquartered in Salt Lake City, Utah, the US.

Scope

- Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Myriad Genetics, Inc. including a breakdown and examination of key business segments
- Intelligence on Myriad Genetics, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Myriad Genetics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Myriad Genetics, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Myriad Genetics, Inc.: Company Overview
Myriad Genetics, Inc.: Overview and Key Facts
Myriad Genetics, Inc.: Overview
Myriad Genetics, Inc.: Key Facts
Myriad Genetics, Inc.: Key Employees
Myriad Genetics, Inc.: Key Employee Biographies
Myriad Genetics, Inc.: Major Products and Services
Myriad Genetics, Inc.: Company History
Myriad Genetics, Inc.: Management Statement
Myriad Genetics, Inc.: Locations and Subsidiaries
Myriad Genetics, Inc.: Key Competitors
Myriad Genetics, Inc.: Company Analysis
Myriad Genetics, Inc.: Business Description
Myriad Genetics, Inc.: SWOT Analysis
Myriad Genetics, Inc.: SWOT Overview
Myriad Genetics, Inc.: Strengths
Myriad Genetics, Inc.: Weaknesses
Myriad Genetics, Inc.: Opportunities
Myriad Genetics, Inc.: Threats
Myriad Genetics, Inc.: Corporate Financial Deals Activity
Myriad Genetics, Inc.: Financial Deals Overview
Myriad Genetics, Inc.: Targets and Partners
Myriad Genetics, Inc.: Top Deals 2016 – 2020YTD*
Myriad Genetics, Inc.: Advisors
Myriad Genetics, Inc.: Top Legal Advisors
Myriad Genetics, Inc.: Top Financial Advisors
Myriad Genetics, Inc.: Mergers and Acquisitions
Myriad Genetics, Inc.: Capital Raising
Myriad Genetics, Inc.: Partnership
Myriad Genetics, Inc.: Recent Developments
Myriad Genetics, Inc.: News and Events Summary
Myriad Genetics, Inc.: Contracts
Myriad Genetics, Inc.: Corporate Governance
Myriad Genetics, Inc.: Financial Performance
Myriad Genetics, Inc.: Market Developments
Myriad Genetics, Inc.: Regulatory and Legal Events
Myriad Genetics, Inc.: Research & Development
Myriad Genetics, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Myriad Genetics, Inc.: Key Facts
Table 2: Myriad Genetics, Inc.: Key Employees
Table 3: Myriad Genetics, Inc.: Company History
Table 4: Myriad Genetics, Inc.: Locations and Subsidiaries
Table 5: Myriad Genetics, Inc.: Key Competitors
Table 6: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Myriad Genetics, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Myriad Genetics, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Myriad Genetics, Inc.: Targets and Partners
Table 10: Myriad Genetics, Inc.: Top Deals 2016 - 2020YTD*
Table 11: Myriad Genetics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Myriad Genetics, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Myriad Genetics, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 14: Myriad Genetics, Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 15: Myriad Genetics, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 16: Myriad Genetics, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 17: Myriad Genetics, Inc.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 18: Myriad Genetics, Inc.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 19: Myriad Genetics, Inc.: News and Events Summary
Table 20: Myriad Genetics, Inc.: Contracts
Table 21: Myriad Genetics, Inc.: Corporate Governance
Table 22: Myriad Genetics, Inc.: Financial Performance
Table 23: Myriad Genetics, Inc.: Market Developments
Table 24: Myriad Genetics, Inc.: Regulatory and Legal Events
Table 25: Myriad Genetics, Inc.: Research & Development
Table 26: Myriad Genetics, Inc.: Strategy and Operations

★調査レポート[Myriad Genetics, Inc.:企業の戦略・SWOT・財務分析] (コード:SWOT20MY4299)販売に関する免責事項を必ずご確認ください。
★調査レポート[Myriad Genetics, Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆